COVID-19
COVID-19 Articles
America and the rest of the world is getting ready for a vaccine that will help protect public health against the COVID-19 pandemic. The societal impact of the coronavirus has changed many lives, and...
Published:
AMC Entertainment Holdings Inc. (NYSE: AMC) will reopen 140 theaters this week. Once they are open, about 70% of its locations nationwide will emerge from the shutdown caused by the COVID-19 crisis....
Published:
24/7 Wall St. has included some highlights from the Zoom Video Communications earnings report, as well as what analysts are saying about the stock after the fact.
Published:
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
Published:
Zoom Communications reported earnings per share (EPS) of $0.92 and $663.5 million in revenue after markets closed Monday. Consensus estimates had called for $0.45 in EPS and $500.45 million in...
Published:
Fluidigm made a splash with the markets on Wednesday morning after the company announced a critical update from the FDA in regards to its COVID-19 test.
Published:
What are India's real confirmed case and death numbers? No one will ever know. A low testing rate and poor procedures for providing COVID-19 deaths mean the numbers are wildly low.
Published:
Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and testing.
Published:
Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.
Published:
XBiotech shares made a handy gain on Monday after the company said that it has identified True Human antibodies that could potentially be used as a therapy against SARS-CoV2.
Published:
Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory filing for a COVID-19 treatment that has been at the center of some...
Published:
AMC Entertainment will offer admission to some of its theaters for 15 cents. The challenge the company faces is that there is a chance people will get sick with COVID-19 there.
Published:
New York State may rank fourth in COVID-19 confirmed case count, but its death toll is well over twice that of any other state in the country.
Published:
There are several academic models of how many Americans will die of COVID-19 this year. One puts the number at well over 500,000.
Published:
When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
Published: